Market open · Delayed intraday data · 2:13 PM ET
Last update: Jun 30, 2026, 2:04 PM ET

Gilead Sciences, Inc. (GILD) — What Changed

$126.33-1.55 (-1.21%) today so far
·Market Open
🔔Major Change Detected
Market Cap
Sector
Healthcare
Drug Manufacturers - General
Next Earnings
Aug 5, 2026
(37 Days)
Relative Volume
Calculating
Calculating
Risk Level
Low
Price Move
-1.21%
1-Day Change
Above 5D Avg: -0.1%
Volume Confirmation
vs 30D Average
Calculating
Catalyst
Earnings Beat
Material / Earnings
Gilead Sciences (GILD) rose 6.3% after reporting EPS of $2.03, beating…
Peer Context
Outperforming
Top 2 of 6 peers
Sector-Wide Move
Signal Quality
Low
Confidence Score
56/100

BestStocks surfaces only meaningful changes—backed by price, volume, catalysts, and peer context—so you can focus on what matters.

1Event Reaction Chart
Price reaction around a key event
GILDGilead Sciences, Inc.$126.33-1.55 (-1.21%)
123.59124.73125.86127.00128.14Price (USD)Jun 23Jun 24Jun 25Jun 26Jun 29126.33
Price Move Up·Jun 26, 2026·+3.26% reaction

1. What Changed Since Last Close

V
Price Move UpMediumMedium
Jun 26+3.26%1.92x vol

GILD rose 3.26% intraday to $127.88, continuing a June 2026 rally that includes a 21% monthly gain. The surge was driven

V
Price Move DownLowLow
Jun 25-1.05%0.7x vol

Gilead Sciences moved -1.05% from $125.16 to $123.84 on 2026-06-25, reaching a new 30-day low. We checked news, earnings

F
New FilingMediumMedium
May 20

Gilead Sciences filed a new 8-K on 2026-05-20, with no stock price movement detected on that date.

E
Earnings BeatMediumMedium
May 7

Gilead Sciences (GILD) rose 6.3% after reporting EPS of $2.03, beating consensus estimates of $1.91 by 6.3%.

E
Earnings BeatMediumMedium
Mar 31

Gilead Sciences reported Q3 EPS of $2.03, beating analyst consensus of $1.91 by 6.2%. The company's profitability exceed

Showing 5 of 5 events

2. Change Timeline

DateChangePrice Reaction Volume Confidence
May 20
FNew Filing
Medium
May 7
EEarnings Beat
Medium
Jun 26
VPrice Move Up
+3.26%1.92xMedium
Mar 31
EEarnings Beat
Medium
Jun 25
VPrice Move Down
-1.05%0.7xLow
Sort:  

3. Why It Moved

1
Primary Catalyst
Earnings Beat
Gilead Sciences (GILD) rose 6.3% after reporting EPS of $2.03, beating consensus
2
Supporting Evidence
  • Gilead Sciences (GILD) rose 6.3% after reporting EPS of $2.03, beating
  • GILD rose 3.26% intraday to $127.88, continuing a June 2026 rally that
  • Gilead Sciences reported Q3 EPS of $2.03, beating analyst consensus of
  • Gilead Sciences moved -1.05% from $125.16 to $123.84 on 2026-06-25, re
3
Nature of Move
Sector-Wide Move
GILD moved broadly in line with sector peers — consistent with a sector or macro-driven event.

4. Peer / Sector Confirmation

SymbolToday5DRel. Vol
GILD-1.21%Leader
LLY+1.81%
UNH-1.89%
JNJ+1.51%
PFE+0.33%
ABBV+0.38%
Sector-Wide Move. Top 2 of 6 peers. GILD moved broadly in line with sector peers — consistent with a sector or macro event.

5. SEC Filing Watch

May 20High
Material event — review for impact
May 7Medium
Quarterly financial results
May 7High
Material event — review for impact
May 4High
Material event — review for impact
Apr 28High
Material event — review for impact
Mar 20Low
Annual proxy — exec compensation & governance
View on SEC EDGAR →Source: filing_snapshots DB · past 120 days

6. Analyst Expectations

No analyst data from FMP — this ticker may have limited coverage or the data is temporarily unavailable.

7. Bull vs Bear Thesis Shift

Bullish Factors
Earnings beat — stock sold off (sell-the-news reaction)
Positive price momentum
Gilead Sciences moved -1.05% from $125.16 to $123.84 on 2026
Bearish Factors
Declined 1.2% despite earnings beat — guidance or outlook concern
Negative session, down 1.2%
New SEC filing — review for material disclosures
Net Thesis Change vs Yesterday
BearishNeutralBullish
Neutral / Mixed+3 / 100

8. What To Watch Next

DateEventImpact
Aug 6est.10-Q FilingMedium
est. = estimated from prior filing cycle
🔔
9. Set Alerts & Get Notified
Get notified when GILD reports earnings, files an 8-K, receives an analyst upgrade, or sees unusual volume.
Earnings alerts
Filing alerts
Volume spikes
Analyst actions

Educational research tool — not personalized investment advice. Data may be delayed.